FDA approves first mRNA flu vaccine, opening new frontiers for the technology

The US FDA has approved Moderna's mRNA-based flu vaccine, the first of its kind. The approval follows the success of mRNA COVID-19 vaccines and signals growing confidence in the technology. Researchers believe mRNA could eventually move beyond vaccines into broader medical treatments, but hurdles remain — including identifying the right diseases to target with the approach.